Berens, ME, Rutka, JT, Rosenblum, ML.
Brain tumour epidemiology, growth, and invasion. Neurosurg Clin Am
1990; 1: 1–18.
Histological Typing of Tumors of the Central Nervous System. Geneva, World Health Organization, 1979.
Cavenee, WK, White, RL.
The genetic basis of cancer. Sci Am March
Bello, MJ, de Campos, JM, Kusak, ME, et al. Ascertainment of chromosome 7 gains in malignant gliomas by cytogenetic and RFLP Analyses. Cancer Genet Cytogenet
1994; 72: 55–58.
Bello, MJ, de Campos, JM, Vaquero, J, et al. Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chromosomes Cancer
1994; 9: 33–41.
Collins, VP, James, CD.
Genes and chromosomal alterations associated with the development of human gliomas. FASEB J
1993; 7: 926–930.
Cavenee, WK, Scrable, HJ, James, CD.
Molecular genetics of human cancer predisposition and progression. Mutat Res
1991; 247: 199–202.
The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol
1994; 53: 11–21.
Gillaspy, GE, Mapstone, TB, Samols, D, Goldthwait, DA.
Transcriptional patterns of growth factors and proto-oncogenes in human glioblastomas and normal glial cells. Cancer Lett
Arita, N, Hayakawa, T, Izumoto, S, et al. Epidermal growth factor receptors in human glioma. J Neurosurg
1989, 70: 916–919.
Fleming, TP, Saxena, A, Clark, WC, et al. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res
Gammeltoft, S, Ballotti, R, Kowalski, A, Westermark, B, Obberghen, EV.
Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res
1988; 48: 1233–1237.
Morrison, RS, Giordano, S, Yamaguchi, , et al. Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells. J Neurosci Res
1993; 34: 502–509.
Batra, SK, Rasheed, BK, Bigner, SH, Bigner, DD.
Biology of disease: oncogenes and anti-oncogenes in human central nervous system tumors. Lab Invest
1994; 71: 621–637.
Von Deimling, A, Eibl, RH, Ohgaki, H, et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res
1992; 52: 2987–2990.
Fults, D, Brockmeyer, D, Tullous, MW, Pedone, CA, Cawthon, RM.
p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res
1992; 52: 674–679.
Sidransky, D, Mikkelsen, T, Schechleimer, K, et al. Clonal expression of p53 mutant cells is associated with brain tumour progression. Nature
1992; 355: 846–847.
El-Azouzi, M, Chung, RY, Farmer, GE, et al. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Nat Acad Sci USA
1989; 86: 7186–7190.
Lang, FF, Miller, DC, Koslow, M, Newcomb, EW.
Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg
Cantley, LC, Auger, KR, Carpenter, C, et al. Oncogenes and signal transduction. Cell
1991; 64: 281–302.
Berra, E, Diaz-Meco, MT, Dominguez, I, et al. Protein kinase C ς isoform is critical for mitogenic signal transduction. Cell
1993; 74: 555–565.
Kolch, W, Heldecker, G, Kochs, G, et al. Protein kinase Ca activates RAF-1 by direct phosphorylation. Nature
1993; 364: 249–252.
Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science
1992; 258: 607–613.
Hug, H, Sarre, TF.
Protein kinase C isoenzymes: divergence in signal transduction?
1993; 291: 329–343.
Dekker, LV, Parker, PJ.
Protein kinase C-a question of specificity. Trends Biol Sci
1994; 19: 73–77.
Selbie, LA, Scmitz-Peiffer, C, Sheng, Y, et al. Molecular cloning and characterization of PKC, an atypical isoform of protein kinase C derived from insulin secreting cells. J Biol Chem
Johannes, FJ, Prestle, J, Eis, S, et al. PKCμ is a novel, atypical member of the protein kinase C family. J Biol Chem
1994; 269: 6140–6148.
Mochly-Rosen, D, Khaner, H, Lopez, J.
Identification of intracellular receptor proteins for activated protein kinase C. Proc Nat Acad Sci USA
Berridge, MJ, Irvine, RF.
Inositol phosphate, a novel second messenger in cellular signal transduction. Nature
1984; 312: 315–321.
Hannun, YA, Bell, RM.
Aminoacridines, potent inhibitors of protein kinase C. J Biol Chem
The potential of protein kinase C as a target for anticancer treatment. Pharmacol Ther
1993; 59: 257–280.
Wetsel, WC, Khan, WA, Merchethaler, I, et al. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol
1992; 117: 121–133.
Fletcher, DJ, Ways, DK.
Age-dependent expression of protein kinase C isoforms in rat islets. Diabetes
1991; 40: 1496–1503.
Osborne, NN, Wood, J, Groome, N.
The occurrence of three calciumindependent protein kinase C subspecies (δ, ε and ς) in the retina of different species. Brain Res
1994; 637: 156–160.
Castagna, M, Takai, Y, Kaibuchi, K, et al. Direct activation of calciumactivated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem
1982; 257: 7847–7851.
Fleischman, LF, Chahwala, SB, Cantley, L.
Ras-transformed cells: altered levels of phosphotidylinositol-4,5-biphosphate and catabolites. Science
1986; 231: 407–410.
O’Brian, CA, Liskamp, RM, Solomon, DH, Weinstein, IB.
Inhibition of protein kinase C by tamoxifen. Cancer Res
1985; 45: 2462–2465.
Alvaro, V, Touraine, P, Vozari, RR, et al. Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cane
The role of protein kinase C in growth control and the concept of carcinogenesis as a progressive disorder in signal transduction. Adv Second Mess and Phosphoprot Res
1990; 24: 307–316.
Gopalakrishna, R, Barsky, SH.
Tumor promotor-induced membranebound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci
Schwartz, GK, Redwood, SM, Ohnuma, T, et al. Inhibition of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J Natl Cancer Inst
1990; 82: 1753–1756.
Blobe, GC, Sachs, CW, Khan, WA, et al. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrugresistant MCF-7 cells. J Biol Chem
1993; 268: 658–664.
Huang, M, Chida, K, Kamata, N, et al. Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts. J Biol Chem
1988; 263: 17975–17980.
Guadagno, SN, Fabbro, D, Weinstein, IB.
Expression of four protein kinase C isoforms in rat fibroblasts. J Biol Chem
Delage, S, Chastre, E, Empereur, S, et al. Increased protein kinase C Ó expression in human colonic caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes. Cancer Res
Eldar, H, Zisman, Y, Ullrich, A, Livneh, E.
Overexpression of protein kinase Cα-subtype in swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J Biol Chem
1990, 265: 13290–13296.
Gruber, JR, Ohno, S, Niles, RM.
Increased expression of protein kinase Ca plays a key role in retinoic acid-induced melanoma differentiation. J Biol Chem
1992; 267: 13356–13360.
Housey, GM, Johnson, MD, Hsiao, WLW, et al. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell
1988; 52: 343–354.
Choi, PM, Tchou-Wong K-M, Weinstein, B.
Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol Cell Biol
1990; 10: 4650–4657.
Yamanishi, DT, Graham, M, Buckmeier, JA, Meykens, FL.
The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis
1991; 12: 105–109.
Cacace, AM, Guadagno, SN, Krauss, RS, Fabbro, D, Weinstein, IB.
The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene
1993; 8: 2095–2104.
Mischak, H, Goodnight, J, Kolch, W, et al. Overexpression of protein kinase C-δ and ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem
1993; 268: 6090–6096.
Tanaka, C, Nishizuka, Y.
The protein kinase C family for neuronal signalling. Ann Rev Neurosci
1994; 17: 551–567.
Ben-Ari, Y, Anikszteijn, L, Bregestovski, P.
Protein kinase C modulation of NMDA currents: an important link for LTP induction. Trends Neurosci
1992; 15: 333–339.
Roivainen, R, McMahon, T, Messing, RO.
Protein kinase C isozymes that mediate enhancement of neurite outgrowth by ethanol and phorbol esters in PC 12 cells. Brain Res
1993; 624: 85–93.
O’Driscoll, KR, Teng, KK, Fabbro, D, Greene, LA, Weinstein, IB.
Selective translocation of protein kinase C-8 in PC 12 cells during nerve growth factor-induced neuritogenesis. Mol Biol Cell
1995; 6: 449–458.
Yong, VW, Sekiguichi, S, Kim, MW, Kim, SU.
Phorbol esters enhances morphological differentiation of oligodendrocytes in culture. J Neurosci Res
1988; 19: 187–194.
Yong, VW, Dooley, NP, Noble, PG.
Protein kinase C in cultured adult human oligodendrocytes: a potential role for isoform a as a mediator of process outgrowth. J Neurosci Res
1994; 39: 83–96.
Protein kinase C-activating tumour promotors enhance the differentiation of astrocytes in aggregating fetal brain cell cultures. J Neurochem
1986; 46: 1561–1566.
Shafit-Zagardo, B, Kume-Iwaki, A, Goldman, JE.
Astrocytes regulate GFAP mRNA levels by cyclic AMP and protein kinase C-dependent mechanisms. Glia
1988; 1: 346–354.
Mobley, PL, Scott, SL, Cruz, EG.
Protein kinase C in astrocytes: a determinant of cell morphology. Brain Res
1986; 398: 366–369.
Harrison, BC, Mobley, PL.
Phorbol ester-induced change in astrocyte morphology: correlation with protein kinase C activation and protein phosphorylation. J Neurosci Res
1990; 25: 71–80.
Murphy, S, McCabe, N, Morrow, C, Pearce, B.
Phorbol ester stimulates proliferation of astrocytes in primary culture. Dev Brain Res
1987; 31: 133–135.
Role of protein kinase C in glial cell proliferation. J Neurosci Res
1989; 22: 20–27.
Sawada, M, Suzumura, A, Ohno, K, Marunouchi, T.
Regulation of astrocyte proliferation by prostaglandin E2 and the a subtype of protein kinase C. Brain Res
1993; 613: 67–73.
Yong, VW, Moumdjian, R, Yong, FP, et al. Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA
Proliferation of human and mouse astrocytes in vitro: signalling through the protein kinase C pathway. J Neurol Sci
Couldwell, WT, Uhm, JH, Antel, JP, Yong, VW.
Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurg
1991; 29: 880–887.
Baltuch, GH, Dooley, NP, Couldwell, WT, Yong, VW.
Staurosporine differentially inhibits glioma versus non-glioma cell lines. J NeuroOnc
1993; 16: 141–147.
Couldwell, WT, Antel, JP, Yong, VW.
Protein kinase C activity correlates with the growth rate of malignant gliomas. II Effects of glioma mitogens and modulators of PKC. Neurosurg
1992; 31: 717–724.
Pollack, IF, Randall, MS, Kristofik, MP, et al. Effects of tamoxifen on DNA synthesis and proliferation of human glioma lines in vitro. Cancer Res
1990; 50: 7134–7138.
Baltuch, GH, Dooley, NP, Rostworowski, KM, Villemure, J-G, Yong, VW.
Protein kinase C isoform a overexpression in C6 glioma and its role in cell proliferation. J NeuroOnc (in press).
Dooley, NP, Baltuch, GB, Paton, A, et al. Phosphorothioate antisense oligonucleotides to protein kinase Ca inhibit human glioma growth in vitro, submitted.
Reifenberger, G, Deckert, M, Wechsler, W.
Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathol
1989; 78: 166–175.
Todo, T, Shitara, N, Nakamura, H, Takakura, K, Ikeda, K.
Immunohistochemical demonstration of protein kinase C isozymes in human brain tumours. Neurosurgery
1991; 108: 11–16.
Benzil, DL, Finkelstein, SD, Epstein, MH, Finch, PW.
Expression pattern of a-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res
1992; 52: 2951–2956.
Raizada, MK, Morse, CA, Gonzales, RA, Crews, FT, Sumners, C.
Receptors for phorbol esters are primarily localized in neurons: comparison of neuronal and glial cultures. Neurochem Res
Saito, N, Kikkawa, U, Nishizuka, Y, Tanaka, C.
Distribution of protein kinase C-like immunoreactive neurons in rat brain. J Neurosci
Clark, EA, Leach, KS, Trojanowski, JQ, Lee, VM-Y.
Characterization and differential distribution of the three major human protein kinase C isozymes (PKCa, PKCp\ and PKCy) of the central nervous system in normal and Alzheimer’s disease brains. Lab Invest
Shimosawa, S, Hachiya, T, Hagiwara, M, et al. Type-specific expression of protein kinase C isozymes in human brain tumours. Neurosci Lett
1990; 108: 11–16.
Misra-Press, A, Fields, AP, Samols, D, Goldthwait, DA.
Protein kinase C isoforms in human glioblastoma cells. Glia
1992; 6: 188–197.
Xiao, H, Goldthwait, DA, Mapstone, T.
The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta. J Neurosurg
1994; 81: 734–740.
Ahmad, S, Mineta, T, Martuza, RL, Glazer, RI.
Antisense expression of protein kinase Cot inhibits the growth and tumourigenicity of human glioblastoma cells. Neurosurgery
1994; 35: 904–909.
Matsumoto, T, Tani, E, Yamaura, , et al. Effects of protein kinase C modulators on multidrug resistance in human glioma cells. Neurosurgery
1995; 36: 565–572.
Yong, VW, Antel, JP.
Culture of glial cells from human brain biopsies. In: Federoff, S, Richardson, A, eds. Protocols for neural cell culture. St Louis: Humana Press, 1992: 81–96.
McConkey, DJ, Hartzell, P, Jondal, M, Orrenius, S.
Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem
1989; 264: 13399–13402.
Jarvis, WD, Turner, AJ, Povirk, LF, Traylor, RS, Grant, S.
Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocyte leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res
1992; 54: 1707–1714.
Haimovitz-Friedman, A, Balaban, N, McLoughlin, M.
et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res
Couldwell, WT, Hinton, DR, He, S, et al. Protein kinase inhibitors induce apoptosis in human malignant glioma lines. FEBS Lett
Weller, M, Frei, K, Groscurth, P.
et al. Anti-Fas/APO-1 antibodymediated apoptosis of cultured human glioma cells. J Clin Invest
Uhm, JH, Dooley, NP, Villemure, J-G, Yong, VW.
Glioma invasion requires a 72 kDa metalloprotease that is regulated by protein kinase C, submitted.
Chambers, TC, Pohl, J, Raynor, RL, et al. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem
1993: 268: 4592–4595.
Zhang, W, Yamada, H, Sakai, N, Niikawa, S, Nozawa, Y.
Enhancement of radiosensitivity by tamoxifen in C6 glioma cells. Neurosurgery
Vertosick, FT, Selker, RG, Pollack, IF, et al. The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of “failed” patients. Neurosurgery
1992: 30: 897–903.
Baltuch, GH, Couldwell, WT, Villemure, J-G.
Protein kinase C inhibitors suppress cell growth in established and low passage cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery
1993; 33: 495–501.
Baltuch, GH, Shenouda, G, Langleben, A, Villemure, J-G.
High dose tamoxifen in the treatment of recurrent high grade glioma: a report of clinical stabilization and tumour regression. Can J Neurol Sci
1993; 20: 168–170.
Couldwell, WT, Weiss, MH, DeGiorgio, CM, et al. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery
1993: 32: 485–490.
Yong, VW, Tejada-Berges, T, Goodyer, CG, Antel, JP, Yong, FP.
Differential proliferative response of human and mouse astrocytes to gamma-interferon. Glia
1992; 6: 269–280.